[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606670":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":10,"responsibleParty":24,"collaborators":10,"id":28,"slug":29,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":33,"acronym":10,"eligibilityCriteria":34,"healthyVolunteers":30,"sex":35,"minAge":36,"maxAge":10,"enrollmentInfo":37,"targetDuration":10,"studyType":40,"phases":10,"briefSummary":41,"conditions":42,"keywords":44,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":10},{"fullName":5,"class":6},"Jagiellonian University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"ALS patients",null,"Patients with diagnosis of ALS and with complaining of dyspnea",[13],{"name":14,"affiliation":5,"role":15},"Jakub M Antczak, MD","PRINCIPAL_INVESTIGATOR",[17,21],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","+48 12 400 25 50","jakub.antczak@uj.edu.pl",{"name":22,"role":18,"phone":19,"phoneExt":10,"email":23},"Gabriela M Rusin, MD","gabriela.rusin@uj.edu.pl",{"type":25,"investigatorFullName":26,"investigatorTitle":27,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Jakub Antczak","Principal Investigator","100606670","polish-version-dyspnea-in-amyotrophic-lateral-sclerosis-100606670",false,"NCT07178574","Polish Version Dyspnea in Amyotrophic Lateral Sclerosis","Validation of Polish Language Version of Dyspnea in Amyotrophic Lateral Sclerosis Outcome Measure","Inclusion Criteria:\n\n* Diagnosis of definite ALS, or probable ALS or probable, laboratory supported ALS according to revised Escorial criteria \\[Brooks et al. 2000\\].\n* Complaining of dyspnea on exertion, or dyspnea at rest, or orthopnea without evidence of pulmonary or cardiac causes of dyspnea.\n\nExclusion Criteria:\n\n* Cognitive impairment severe enough to interfere with study process.","ALL","18 Years",{"count":38,"type":39},120,"ESTIMATED","OBSERVATIONAL","Amyotrophic lateral sclerosis is a fatal disease with progressive degeneration of central and peripheral motor neurons. Weakness of pharyngeal and respiratory muscles lead to dyspnea, which is present in up to 80% of patients. Dyspnea in Amyotrophic Lateral Sclerosis (DALS-15) is a questionnaire designed to measure the severity of dyspnea. DALS-15 was originally created in German language. The aim of this study is to validate the Polish-language version of DALS-15.",[43],"Amyotrophic Lateral Sclerosis",[43,45,46,47,48],"dyspnea","DALS-15","validation","Polish-language version","NOT_YET_RECRUITING","2025-09-16",{"date":52,"type":53},"2025-09-19","ACTUAL",{"date":55,"type":39},"2025-10-01",{"date":57,"type":39},"2028-06-30",{"name":26,"class":6}]